Published in N Engl J Med on December 20, 1990
Pemphigus autoimmunity: hypotheses and realities. Autoimmunity (2011) 1.23
Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest (1998) 1.20
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med (2007) 1.10
Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis (2012) 1.03
Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci (2010) 1.03
Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases. J Invest Dermatol (2013) 1.01
Periplakin gene targeting reveals a constituent of the cornified cell envelope dispensable for normal mouse development. Mol Cell Biol (2004) 1.01
The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int (2011) 0.94
Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol (2014) 0.94
Paraneoplastic dermatological manifestation of gastrointestinal malignancies. World J Gastroenterol (2009) 0.94
Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med (1995) 0.93
Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid. Ann Dermatol (2012) 0.87
Molecular diagnosis in autoimmune skin blistering conditions. Curr Mol Med (2014) 0.87
The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS One (2010) 0.86
Paraneoplastic pemphigus: an uncommon cause of chronic cicatrising conjunctivitis. BMJ Case Rep (2009) 0.85
Anaplastic large cell lymphoma presenting with paraneoplastic pemphigus. J Clin Pathol (2007) 0.84
Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest (1992) 0.84
Pemphigus. Dent Clin North Am (2013) 0.84
Desmosomes in acquired disease. Cell Tissue Res (2015) 0.83
Autoantibodies to desmoplakin I and II in patients with erythema multiforme. J Exp Med (1995) 0.83
Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature. World J Surg Oncol (2007) 0.83
Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice. J Clin Invest (2011) 0.82
Analysis of the reactivity of indirect immunofluorescence in patients with pemphigus foliaceus and pemphigus vulgaris using rat bladder epithelium as a substrate. Clinics (Sao Paulo) (2011) 0.81
Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: a single-center experience of 22 cases. J Cancer Res Clin Oncol (2011) 0.81
Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus. Arch Dermatol Res (1994) 0.80
Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues. J Clin Immunol (2000) 0.80
Inflammatory myofibroblastic tumor on intercostal nerve presenting as paraneoplastic pemphigus with fatal pulmonary involvement. J Korean Med Sci (2007) 0.80
Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis. Am J Pathol (1997) 0.79
Paraneoplastic pemphigus: a paraneoplastic autoimmune multiorgan syndrome or autoimmune multiorganopathy? Case Rep Dermatol Med (2012) 0.78
Cardiac autoantibodies from patients affected by a new variant of endemic pemphigus foliaceus in Colombia, South America. J Clin Immunol (2011) 0.78
Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol (2015) 0.78
A case of paraneoplastic pemphigus associated with Castleman's disease. An Bras Dermatol (2013) 0.78
The skin: a mirror to the gut. Int J Colorectal Dis (2013) 0.76
Inflammatory myofibroblastic tumor presenting as paraneoplastic pemphigus in a 7-year-old girl. JAAD Case Rep (2016) 0.75
A case report of paraneoplastic pemphigus associated with esophageal squamous cell carcinoma. Cancer Res Treat (2013) 0.75
Recurrent corneal melting in the paraneoplastic pemphigus associated with Castleman's disease. BMC Ophthalmol (2016) 0.75
Paraneoplastic pemphigus in a burn intensive care unit: case report and review of the literature. J Burn Care Res (2010) 0.75
Peri-anal Paraneoplastic Pemphigus Heralding the Relapse of Follicular Lymphoma and Its Successful Management by Rituximab: A Short Correspondence. Indian J Hematol Blood Transfus (2016) 0.75
Dramatic resolution of bullous pemphigoid after surgery for gastric cancer: A case report. Int J Surg Case Rep (2014) 0.75
Paraneoplastic pemphigus presenting as mild cutaneous features of pemphigus foliaceus and lichenoid stomatitis with antidesmoglein 1 antibodies. Dermatol Res Pract (2010) 0.75
Oral lesions and lymphoproliferative disorders. J Oncol (2010) 0.75
A middle-aged man presenting with unexplained mucosal erosions and progressive dyspnoea. BMJ Case Rep (2015) 0.75
Clinical profile of cutaneous manifestations with and without hematologic disease: A comparative study. Indian Dermatol Online J (2014) 0.75
Castleman's Disease Presenting as Localized Abdominal Mass and Paraneoplastic Pemphigus. J Clin Imaging Sci (2016) 0.75
Paraneoplastic pemphigus: a short review. Clin Cosmet Investig Dermatol (2016) 0.75
Paraneoplastic Pemphigus Associated with a Malignant Thymoma: A Case of Persistent and Refractory Oral Ulcerations Following Thymectomy. Ann Dermatol (2017) 0.75
Paraneoplastic pemphigus presenting with a single oral lesion. BMJ Case Rep (2013) 0.75
High-dose-rate intraluminal brachytherapy for paraneoplastic autoimmune multiorgan syndrome. Exp Ther Med (2016) 0.75
An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases. J Clin Immunol (1997) 0.75
Analysis of Serum Cytokine Profile in Pemphigus. Ann Dermatol (2017) 0.75
Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy. Int J Hematol (2017) 0.75
Pemphigus with thymoma improved by thymectomy: report of a case. Surg Today (2012) 0.75
Class-IIS restriction enzymes--a review. Gene (1991) 4.70
CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell (1992) 3.70
Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell (1991) 3.42
Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol (1997) 3.02
The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett (1998) 3.00
Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell (1981) 2.72
Visualization of centromere proteins CENP-B and CENP-C on a stable dicentric chromosome in cytological spreads. Chromosoma (1989) 2.71
Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med (2000) 2.68
Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature (1993) 2.68
Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun (1998) 2.67
A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res (1980) 2.53
Ocular involvement in chronic sarcoidosis. Am J Ophthalmol (1986) 2.41
cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci U S A (1988) 2.38
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol (1997) 2.23
Pemphigus: is there another half of the story? J Invest Dermatol (2001) 2.22
Recurrence of pemphigus vulgaris associated with interleukin 2 therapy. Arch Dermatol (1994) 2.03
Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem (1984) 1.96
Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest (1984) 1.92
Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest (1982) 1.90
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest (1999) 1.87
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood (1989) 1.85
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum (2001) 1.85
Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem (1996) 1.81
Desmoglein 3 anchors telogen hair in the follicle. J Cell Sci (1998) 1.77
Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest (1992) 1.77
Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N Engl J Med (1989) 1.72
Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology (2001) 1.72
Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med (1984) 1.67
Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest (1990) 1.67
Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group. Arch Ophthalmol (1996) 1.66
Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology (1989) 1.66
Nomenclature of the desmosomal cadherins. J Cell Biol (1993) 1.65
Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int (2006) 1.65
Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest (1998) 1.64
Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG (2009) 1.64
Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc Natl Acad Sci U S A (2000) 1.62
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol (1984) 1.61
A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant (2011) 1.60
Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol (1986) 1.56
Plant genetic diversity in the Canary Islands: a conservation perspective. Am J Bot (2000) 1.53
Objective evaluation of treatment effects on port-wine stains using L*a*b* color coordinates. Plast Reconstr Surg (2001) 1.52
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst (1997) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Current efficacy of postexposure prophylaxis against measles with immunoglobulin. J Pediatr (2001) 1.46
A rapid and simple spectrophotometric assay of angiotensin-converting enzyme. Anal Biochem (1978) 1.46
Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med (2000) 1.43
Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol (1996) 1.42
Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol (2000) 1.41
Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int J Biol Macromol (1992) 1.40
Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production. Br J Pharmacol (2008) 1.39
Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol (1991) 1.39
A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem Biophys Res Commun (1996) 1.39
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res (1999) 1.38
Mechanisms of relaxation induced by activation of beta-adrenoceptors in smooth muscle cells of the guinea-pig mesenteric artery. J Physiol (1982) 1.38
Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas. Int J Cancer (1999) 1.37
Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest (1988) 1.37
Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol (1996) 1.36
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer. Br J Cancer (2009) 1.36
Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem (1991) 1.35
A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) (2000) 1.34
A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol (1989) 1.34
Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol (2001) 1.34
Antigenic specificity of fogo selvagem autoantibodies is similar to North American pemphigus foliaceus and distinct from pemphigus vulgaris autoantibodies. J Invest Dermatol (1986) 1.34
Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus. FEBS Lett (1998) 1.33
Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Br J Anaesth (2009) 1.32
Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines. Oncogene (2007) 1.32
The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol (1998) 1.30
Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology (1994) 1.29
Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med (1985) 1.28
Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol (1991) 1.28
HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol (2007) 1.27
p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene (2001) 1.26
Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol (1989) 1.26
CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. Stroke (1999) 1.25
Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry (2000) 1.25
Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol (1984) 1.25
Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol (1994) 1.25
Specific epidermal protein markers are modulated during calcium-induced terminal differentiation. J Cell Biol (1983) 1.24
Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res (1997) 1.24
Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol (1990) 1.24
Epidermal cell culture. Transplant Proc (1980) 1.24
Pars planitis: clinical features and class II HLA associations. Ophthalmology (1999) 1.22
A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol (1986) 1.22
Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene (2000) 1.21
Summary of the II International Symposium on Cytomegalovirus. Antiviral Res (1998) 1.21
Desmoglein isoform distribution affects stratum corneum structure and function. J Cell Biol (2001) 1.21
Sequence and expression of the chicken beta 3 tubulin gene. A vertebrate testis beta-tubulin isotype. J Biol Chem (1986) 1.19
Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. J Exp Med (1987) 1.19
Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer (2004) 1.19
Molecular analysis of rice plants harboring an Ac/Ds transposable element-mediated gene trapping system. Plant J (1999) 1.19
Factors affecting attrition in a longitudinal study of patients with AIDS. AIDS Care (2006) 1.19
Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J Virol (2001) 1.18
Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene (2008) 1.18
Dyschromatosis universalis hereditaria: an electron microscopic examination. J Dermatol (1997) 1.17
Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br J Cancer (2001) 1.17
miranda localizes staufen and prospero asymmetrically in mitotic neuroblasts and epithelial cells in early Drosophila embryogenesis. Development (1998) 1.17